Inter Ocean Capital Group, LLC Edwards Lifesciences Corp Transaction History

Inter Ocean Capital Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$61.71 - $77.76 $22,215 - $27,993	-360 Reduced 10.44%	3,089 $235,000
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $137,659 - $185,546	-1,987 Reduced 36.55%	3,449 $238,000
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $176,089 - $204,035	-2,163 Reduced 28.46%	5,436 $512,000
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $22,500 - $25,606	-303 Reduced 3.83%	7,599 $628,000
Q4 2022 Feb 08, 2023	SELL	$68.3 - $87.44 $3,824 - $4,896	-56 Reduced 0.7%	7,902 $589,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $152,878 - $199,130	1,856 Added 30.42%	7,958 $658,000
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $527,823 - $782,703	6,102 New	6,102 $580,000
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $159,771 - $201,108	-1,567 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $166,681 - $204,775	1,567 New	1,567 $203,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Inter Ocean Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Inter Ocean Capital Group, LLC with notifications on news.